BACTROBAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bactroban, and what generic alternatives are available?
Bactroban is a drug marketed by Glaxosmithkline and is included in three NDAs.
The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bactroban
A generic version of BACTROBAN was approved as mupirocin by PADAGIS ISRAEL on November 7th, 2003.
Summary for BACTROBAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 19 |
Patent Applications: | 4,627 |
Drug Prices: | Drug price information for BACTROBAN |
What excipients (inactive ingredients) are in BACTROBAN? | BACTROBAN excipients list |
DailyMed Link: | BACTROBAN at DailyMed |
Recent Clinical Trials for BACTROBAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lindenhofgruppe AG | Phase 4 |
Lindenhof AG | Phase 4 |
National Jewish Health | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for BACTROBAN
US Patents and Regulatory Information for BACTROBAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | BACTROBAN | mupirocin calcium | CREAM;TOPICAL | 050746-001 | Dec 11, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline | BACTROBAN | mupirocin calcium | OINTMENT;NASAL | 050703-001 | Sep 18, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline | BACTROBAN | mupirocin | OINTMENT;TOPICAL | 050591-001 | Dec 31, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BACTROBAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BACTROBAN | mupirocin calcium | OINTMENT;NASAL | 050703-001 | Sep 18, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | BACTROBAN | mupirocin calcium | CREAM;TOPICAL | 050746-001 | Dec 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | BACTROBAN | mupirocin calcium | CREAM;TOPICAL | 050746-001 | Dec 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BACTROBAN
See the table below for patents covering BACTROBAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S6117583 | CRYSTALLINE CALCIUM PSEUDOMONATE, MANUFACTURE AND MEDICINAL COMPOSITION | ⤷ Sign Up |
Norway | 852446 | ⤷ Sign Up | |
Slovenia | 8511013 | PROCESS FOR PREPARATION OF CRYSTALLINE CALCIUM PSEUDOMONATE OR ITS HYDRATE | ⤷ Sign Up |
United Kingdom | 8415579 | ⤷ Sign Up | |
Zambia | 4185 | NOVEL COMPOUNDS | ⤷ Sign Up |
Finland | 852407 | ⤷ Sign Up | |
Canada | 1242437 | PSEUDOMONATE DE CALCIUM CRISTALLIN (CRYSTALLINE CALCIUM PSEUDOMONATE) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |